OPKO Health Depreciation & Amortization 2011-2026 | OPK

Annual Depreciation & Amortization OPKO Health

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
98.2 M	105 M	109 M	78.7 M	85.4 M	93.8 M	97.3 M	102 M	96.6 M	42.2 M	14.9 M	15.2 M	10.2 M	3.83 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
109 M	3.83 M	68 M

Quarterly Depreciation & Amortization OPKO Health

2026-Q1	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
22.2 M	23 M	23.5 M	24.2 M	24.2 M	25.8 M	26.2 M	26.4 M	26.4 M	-	28 M	28 M	27.8 M	-	19 M	20.6 M	20 M	-	21 M	22.3 M	22.1 M	-	23.8 M	23.7 M	23.8 M	-	23.9 M	24.8 M	24.8 M	-	25.4 M	25.6 M	25.7 M	-	25.8 M	24.6 M	22.2 M	-	12.4 M	4.15 M	3.52 M	-	3.77 M	4.03 M	3.56 M	-	3.77 M	3.45 M	3.43 M	-	2.66 M	2.45 M	2.33 M	-	1.04 M	936 K	869 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
28 M	869 K	17.3 M

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Myriad Genetics MYGN	53.7 M	$ 4.11	-18.29 %	$ 381 M	USA
National Research Corporation NRC	7.62 M	$ 17.86	-4.7 %	$ 400 M	USA
Koninklijke Philips N.V. PHG	1.12 B	$ 27.23	2.95 %	$ 20 B	Niderland
Burning Rock Biotech Limited BNR	47.8 M	$ 17.01	-0.09 %	$ 179 M	China
Agilent Technologies A	321 M	$ 117.69	0.14 %	$ 35.8 B	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
CareDx, Inc CDNA	15 M	$ 20.94	1.16 %	$ 1.12 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Co-Diagnostics CODX	1.11 M	$ 1.64	3.14 %	$ 2.18 M	USA
Castle Biosciences CSTL	40.8 M	$ 24.75	0.61 %	$ 687 M	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
Medpace Holdings MEDP	27.2 M	-	-	$ 12.3 B	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Charles River Laboratories International CRL	403 M	$ 181.73	-1.97 %	$ 9.01 B	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
NeoGenomics NEO	36.1 M	$ 8.89	0.34 %	$ 1.14 B	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Natera NTRA	16.7 M	$ 215.09	4.02 %	$ 21.2 B	USA
Fulgent Genetics FLGT	24.9 M	$ 14.92	0.13 %	$ 451 M	USA
Personalis PSNL	10.9 M	$ 6.07	9.17 %	$ 360 M	USA
Guardant Health GH	39.7 M	$ 92.25	3.05 %	$ 11.6 B	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
Soleno Therapeutics SLNO	2.02 M	$ 52.94	0.04 %	$ 2.69 B	USA
ICON Public Limited Company ICLR	488 M	$ 124.13	2.32 %	$ 10.2 B	Irlanda
Illumina ILMN	354 M	$ 142.58	2.52 %	$ 22.7 B	USA
Senseonics Holdings SENS	1.51 M	$ 5.36	7.2 %	$ 224 M	USA
Interpace Biosciences IDXG	425 K	-	-	$ 9.33 M	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Thermo Fisher Scientific TMO	1.05 B	$ 472.95	1.33 %	$ 178 B	USA
Biomerica BMRA	87 K	$ 2.21	1.14 %	$ 5.08 M	USA
Lantheus Holdings LNTH	70.1 M	$ 86.15	0.38 %	$ 5.81 B	USA
Laboratory Corporation of America Holdings LH	681 M	$ 256.94	-0.08 %	$ 21.4 B	USA
Twist Bioscience Corporation TWST	24.9 M	$ 59.53	4.99 %	$ 3.56 B	USA
Celcuity CELC	167 K	-	-	$ 6.52 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	119 M	$ 9.18	-0.97 %	$ 1.99 B	USA
Waters Corporation WAT	88.1 M	$ 349.53	1.98 %	$ 20.8 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 189.13	-0.9 %	$ 21 B	USA